jamesbrey-istockphoto-com-court-gavel-

JamesBrey / iStockphoto.com

2 May 2017Americas

ANDA disputes drop in 2016, says report

The number of Abbreviated New Drug Application (ANDA) disputes filed in 2016 represented a drop for the first time in three years, the newly published “Hatch-Waxman ANDA Litigation Report 2017” has said.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Fed Circ orders Teva to delist five patents from Orange Book

Sarepta wins $115M in patent dispute over muscular dystrophy drug

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York